Misplaced Pages

Technetium (Tc) mertiatide

Clinical data
Trade names	Technescan Mag3
License data	US DailyMed: Tc 99m mertiatide
Routes of administration	Intravenous
ATC code	V09CA03 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
CAS Number	125224-05-7
PubChem CID	11441509
ChemSpider	32702040
UNII	36ITO9SKQJ
KEGG	D06039
Chemical and physical data
3D model (JSmol)	Interactive image
SMILES C(C(=NCC(=O)))N=C(CN=C(C)).O=..
InChI InChI=1S/C8H13N3O5S.2Na.O.Tc/c12-5(2-10-7(14)4-17)9-1-6(13)11-3-8(15)16;;;;/h17H,1-4H2,(H,9,12)(H,10,14)(H,11,13)(H,15,16);;;;/q;2*+1;;+3/p-5/i;;;;1+1 Key:JVYYEQVAPXSUSY-RCUQKECRSA-I

Technetium (Tc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys. It is a renal imaging agent that is given by intravenous injection.

It was approved for medical use in the United States in June 1990.

Medical uses

Technetium (Tc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi.

Chemistry

The active ingredient, betiatide, is reconstituted with sodium pertechnetate Tc injection to form technetium (Tc) mertiatide.

References

1. ^ "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December 2022. Archived from the original on 2 February 2023. Retrieved 1 February 2023.
2. "Technescan Mag3: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 13 December 2022. Retrieved 1 February 2023.

• Medicine

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Technetium-99m
• Radiopharmaceuticals
• Pharmacology stubs